Zebrafish Models of Cancer—New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate
Abstract
:1. Introduction
2. Genetic Models of Cancer in Zebrafish
2.1. Zebrafish and New Methods for Cancer Modelling
2.2. Zebrafish Cancer Models and Epigenetics
3. Transplantation Models—Allografts and Xenografts
3.1. Zebrafish as a Model for Allogeneic Transplantation
3.2. Zebrafish Xenotransplantation Model for the Evaluation of Cancer Progress and Metastasis
3.3. Drug Screening in Zebrafish and Its Future as a Pre-clinical Model
4. Conclusions
Funding
Acknowledgments
Conflicts of Interest
References
- Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646–674. [Google Scholar] [CrossRef] [PubMed]
- Mroz, E.A.; Rocco, J.W. The challenges of tumor genetic diversity. Cancer 2017, 123, 917–927. [Google Scholar] [CrossRef] [PubMed]
- Grzywa, T.M.; Paskal, W.; Wlodarski, P.K. Intratumor and Intertumor Heterogeneity in Melanoma. Transl. Oncol. 2017, 10, 956–975. [Google Scholar] [CrossRef] [PubMed]
- Cagan, R.L.; Zon, L.I.; White, R.M. Modeling Cancer with Flies and Fish. Dev. Cell 2019, 49, 317–324. [Google Scholar] [CrossRef] [PubMed]
- McCune, J.M.; Namikawa, R.; Kaneshima, H.; Shultz, L.D.; Lieberman, M.; Weissman, I.L. The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 1988, 241, 1632–1639. [Google Scholar] [CrossRef] [PubMed]
- Bock, B.C.; Stein, U.; Schmitt, C.A.; Augustin, H.G. Mouse models of human cancer. Cancer Res. 2014, 74, 4671–4675. [Google Scholar] [CrossRef]
- Capasso, A.; Lang, J.; Pitts, T.M.; Jordan, K.R.; Lieu, C.H.; Davis, S.L.; Diamond, J.R.; Kopetz, S.; Barbee, J.; Peterson, J.; et al. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts. J. Immunother. Cancer 2019, 7, 37. [Google Scholar] [CrossRef]
- van der Weyden, L.; Patton, E.E.; Wood, G.A.; Foote, A.K.; Brenn, T.; Arends, M.J.; Adams, D.J. Cross-species models of human melanoma. J. Pathol. 2016, 238, 152–165. [Google Scholar] [CrossRef]
- Kucinska, M.; Murias, M.; Nowak-Sliwinska, P. Beyond mouse cancer models: Three-dimensional human-relevant in vitro and non-mammalian in vivo models for photodynamic therapy. Mutat. Res. 2017, 773, 242–262. [Google Scholar] [CrossRef]
- Sarasamma, S.; Lai, Y.H.; Liang, S.T.; Liu, K.; Hsiao, C.D. The Power of Fish Models to Elucidate Skin Cancer Pathogenesis and Impact the Discovery of New Therapeutic Opportunities. Int. J. Mol. Sci. 2018, 19, 3929. [Google Scholar] [CrossRef]
- Schartl, M.; Walter, R.B. Xiphophorus and Medaka Cancer Models. Adv. Exp. Med. Biol. 2016, 916, 531–552. [Google Scholar] [PubMed]
- Hyodo-Taguchi, Y.; Matsudaira, H. Induction of transplantable melanoma by treatment with N-methyl-N’-nitro-N-nitrosoguanidine in an inbred strain of the teleost Oryzias latipes. J. Natl. Cancer Inst. 1984, 73, 1219–1227. [Google Scholar] [PubMed]
- Kimmel, C.B.; Ballard, W.W.; Kimmel, S.R.; Ullmann, B.; Schilling, T.F. Stages of embryonic development of the zebrafish. Dev. Dyn. 1995, 203, 253–310. [Google Scholar] [CrossRef] [PubMed]
- Haffter, P.; Granato, M.; Brand, M.; Mullins, M.C.; Hammerschmidt, M.; Kane, D.A.; Odenthal, J.; van Eeden, F.J.; Jiang, Y.J.; Heisenberg, C.P.; et al. The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 1996, 123, 1–36. [Google Scholar] [PubMed]
- White, R.; Rose, K.; Zon, L. Zebrafish cancer: The state of the art and the path forward. Nat. Rev. Cancer 2013, 13, 624–636. [Google Scholar] [CrossRef]
- White, R.M.; Sessa, A.; Burke, C.; Bowman, T.; LeBlanc, J.; Ceol, C.; Bourque, C.; Dovey, M.; Goessling, W.; Burns, C.E.; et al. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2008, 2, 183–189. [Google Scholar] [CrossRef]
- Payne, E.; Look, T. Zebrafish modelling of leukaemias. Br. J. Haematol. 2009, 146, 247–256. [Google Scholar] [CrossRef]
- Veinotte, C.J.; Dellaire, G.; Berman, J.N. Hooking the big one: The potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era. Dis. Models Mech. 2014, 7, 745–754. [Google Scholar] [CrossRef]
- Kirchberger, S.; Sturtzel, C.; Pascoal, S.; Distel, M. Quo natas, Danio?-Recent Progress in Modeling Cancer in Zebrafish. Front. Oncol. 2017, 7, 186. [Google Scholar] [CrossRef]
- Mathias, J.R.; Dodd, M.E.; Walters, K.B.; Yoo, S.K.; Ranheim, E.A.; Huttenlocher, A. Characterization of zebrafish larval inflammatory macrophages. Dev. Comp. Immunol. 2009, 33, 1212–1217. [Google Scholar] [CrossRef]
- Ellett, F.; Pase, L.; Hayman, J.W.; Andrianopoulos, A.; Lieschke, G.J. mpeg1 promoter transgenes direct macrophage-lineage expression in zebrafish. Blood 2011, 117, E49–E56. [Google Scholar] [CrossRef] [PubMed]
- He, S.; Lamers, G.E.; Beenakker, J.W.; Cui, C.; Ghotra, V.P.; Danen, E.H.; Meijer, A.H.; Spaink, H.P.; Snaar-Jagalska, B.E. Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model. J. Pathol. 2012, 227, 431–445. [Google Scholar] [CrossRef] [PubMed]
- Howe, K.; Clark, M.D.; Torroja, C.F.; Torrance, J.; Berthelot, C.; Muffato, M.; Collins, J.E.; Humphray, S.; McLaren, K.; Matthews, L.; et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature 2013, 496, 498–503. [Google Scholar] [CrossRef] [PubMed]
- Taylor, A.M.; Zon, L.I. Zebrafish tumor assays: The state of transplantation. Zebrafish 2009, 6, 339–346. [Google Scholar] [CrossRef] [PubMed]
- Eguiara, A.; Holgado, O.; Beloqui, I.; Abalde, L.; Sanchez, Y.; Callol, C.; Martin, A.G. Xenografts in zebrafish embryos as a rapid functional assay for breast cancer stem-like cell identification. Cell Cycle 2011, 10, 3751–3757. [Google Scholar] [CrossRef] [PubMed]
- Brown, H.K.; Schiavone, K.; Tazzyman, S.; Heymann, D.; Chico, T.J. Zebrafish xenograft models of cancer and metastasis for drug discovery. Expert Opin. Drug Discov. 2017, 12, 379–389. [Google Scholar] [CrossRef] [PubMed]
- Fior, R.; Póvoa, V.; Mendes, R.V.; Carvalho, T.; Gomes, A.; Figueiredo, N.; Ferreira, M.G. Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts. Proc. Natl. Acad. Sci. USA 2017, 114, E8234–E8243. [Google Scholar] [CrossRef] [PubMed]
- Letrado, P.; de Miguel, I.; Lamberto, I.; Diez-Martinez, R.; Oyarzabal, J. Zebrafish: Speeding Up the Cancer Drug Discovery Process. Cancer Res. 2018, 78, 6048–6058. [Google Scholar] [CrossRef]
- Spence, R.; Gerlach, G.; Lawrence, C.; Smith, C. The behaviour and ecology of the zebrafish, Danio rerio. Biol. Rev. 2008, 83, 13–34. [Google Scholar] [CrossRef]
- Force, A.; Lynch, M.; Pickett, F.B.; Amores, A.; Yan, Y.L.; Postlethwait, J. Preservation of duplicate genes by complementary, degenerative mutations. Genetics 1999, 151, 1531–1545. [Google Scholar]
- Taylor, J.S.; Braasch, I.; Frickey, T.; Meyer, A.; Van de Peer, Y. Genome duplication, a trait shared by 22,000 species of ray-finned fish. Genome Res. 2003, 13, 382–390. [Google Scholar] [CrossRef] [PubMed]
- Callahan, S.J.; Tepan, S.; Zhang, Y.M.; Lindsay, H.; Burger, A.; Campbell, N.R.; Kim, I.S.; Hollmann, T.J.; Studer, L.; Mosimann, C.; et al. Cancer modeling by Transgene Electroporation in Adult Zebrafish (TEAZ). Dis. Models Mech. 2018, 11, dmm034561. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Stuelten, C.H.; Parent, C.A.; Montell, D.J. Cell motility in cancer invasion and metastasis: Insights from simple model organisms. Nat. Rev. Cancer 2018, 18, 296–312. [Google Scholar] [CrossRef]
- Dawson, M.A.; Kouzarides, T. Cancer Epigenetics: From Mechanism to Therapy. Cell 2012, 150, 12–27. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chernyavskaya, Y.; Kent, B.; Sadler, K.C. Zebrafish Discoveries in Cancer Epigenetics. Adv. Exp. Med. Biol. 2016, 916, 169–197. [Google Scholar] [PubMed] [Green Version]
- Schultz, L.E.; Haltom, J.A.; Almeida, M.P.; Wierson, W.A.; Solin, S.L.; Weiss, T.J.; Helmer, J.A.; Sandquist, E.J.; Shive, H.R.; McGrail, M. Epigenetic regulators Rbbp4 and Hdac1 are overexpressed in a zebrafish model of RB1 embryonal brain tumor, and are required for neural progenitor survival and proliferation. Dis. Models Mech. 2018, 11, dmm034124. [Google Scholar] [CrossRef] [Green Version]
- Beckwith, L.G.; Moore, J.L.; Tsao-Wu, G.S.; Harshbarger, J.C.; Cheng, K.C. Ethylnitrosourea induces neoplasia in zebrafish (Danio rerio). Labor. Investig. 2000, 80, 379–385. [Google Scholar] [CrossRef] [Green Version]
- Spitsbergen, J.M.; Tsai, H.W.; Reddy, A.; Miller, T.; Arbogast, D.; Hendricks, J.D.; Bailey, G.S. Neoplasia in zebrafish (Danio rerio) treated with N-methyl-N’-nitro-N-nitrosoguanidine by three exposure routes at different developmental stages. Toxicol. Pathol. 2000, 28, 716–725. [Google Scholar] [CrossRef]
- Berghmans, S.; Murphey, R.D.; Wienholds, E.; Neuberg, D.; Kutok, J.L.; Fletcher, C.D.; Morris, J.P.; Liu, T.X.; Schulte-Merker, S.; Kanki, J.P.; et al. tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc. Natl. Acad. Sci. USA 2005, 102, 407–412. [Google Scholar] [CrossRef] [Green Version]
- Ignatius, M.S.; Hayes, M.N.; Moore, F.E.; Tang, Q.; Garcia, S.P.; Blackburn, P.R.; Baxi, K.; Wang, L.; Jin, A.; Ramakrishnan, A.; et al. tp53 deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish. Elife 2018, 7, e37202. [Google Scholar] [CrossRef]
- Koster, R.; Sassen, W.A. A molecular toolbox for genetic manipulation of zebrafish. Adv. Genom. Genet. 2015, 5, 151. [Google Scholar] [CrossRef] [Green Version]
- Langenau, D.M.; Traver, D.; Ferrando, A.A.; Kutok, J.L.; Aster, J.C.; Kanki, J.P.; Lin, S.; Prochownik, E.; Trede, N.S.; Zon, L.I.; et al. Myc-induced T cell leukemia in transgenic zebrafish. Science 2003, 299, 887–890. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Langenau, D.M.; Keefe, M.D.; Storer, N.Y.; Jette, C.A.; Smith, A.C.; Ceol, C.J.; Bourque, C.; Look, A.T.; Zon, L.I. Co-injection strategies to modify radiation sensitivity and tumor initiation in transgenic Zebrafish. Oncogene 2008, 27, 4242–4248. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Langenau, D.M.; Keefe, M.D.; Storer, N.Y.; Guyon, J.R.; Kutok, J.L.; Le, X.; Goessling, W.; Neuberg, D.S.; Kunkel, L.M.; Zon, L.I. Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev. 2007, 21, 1382–1395. [Google Scholar] [CrossRef] [Green Version]
- Patton, E.E.; Widlund, H.R.; Kutok, J.L.; Kopani, K.R.; Amatruda, J.F.; Murphey, R.D.; Berghmans, S.; Mayhall, E.A.; Traver, D.; Fletcher, C.D.; et al. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr. Biol. 2005, 15, 249–254. [Google Scholar] [CrossRef] [Green Version]
- Patton, E.E.; Zon, L.I. Taking human cancer genes to the fish: A transgenic model of melanoma in zebrafish. Zebrafish 2005, 1, 363–368. [Google Scholar] [CrossRef]
- Mensah, L.; Ferguson, J.L.; Shive, H.R. Genotypic and Phenotypic Variables Affect Meiotic Cell Cycle Progression, Tumor Ploidy, and Cancer-Associated Mortality in a brca2-Mutant Zebrafish Model. J. Oncol. 2019, 2019, 9218251. [Google Scholar] [CrossRef]
- Shive, H.R.; West, R.R.; Embree, L.J.; Azuma, M.; Sood, R.; Liu, P.; Hickstein, D.D. brca2 in zebrafish ovarian development, spermatogenesis, and tumorigenesis. Proc. Natl. Acad. Sci. USA 2010, 107, 19350–19355. [Google Scholar] [CrossRef] [Green Version]
- Mort, R.L.; Jackson, I.J.; Patton, E.E. The melanocyte lineage in development and disease. Development 2015, 142, 1387. [Google Scholar] [CrossRef] [Green Version]
- Kaufman, C.K.; Mosimann, C.; Fan, Z.P.; Yang, S.; Thomas, A.J.; Ablain, J.; Tan, J.L.; Fogley, R.D.; van Rooijen, E.; Hagedorn, E.J.; et al. A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation. Science 2016, 351, aad2197. [Google Scholar] [CrossRef] [Green Version]
- Santoriello, C.; Deflorian, G.; Pezzimenti, F.; Kawakami, K.; Lanfrancone, L.; d’Adda di Fagagna, F.; Mione, M. Expression of H-RASV12 in a zebrafish model of Costello syndrome causes cellular senescence in adult proliferating cells. Dis. Models Mech. 2009, 2, 56–67. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Santoriello, C.; Gennaro, E.; Anelli, V.; Distel, M.; Kelly, A.; Köster, R.W.; Hurlstone, A.; Mione, M. Kita Driven Expression of Oncogenic HRAS Leads to Early Onset and Highly Penetrant Melanoma in Zebrafish. PLoS ONE 2010, 5, e15170. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Anelli, V.; Villefranc, J.A.; Chhangawala, S.; Martinez-McFaline, R.; Riva, E.; Nguyen, A.; Verma, A.; Bareja, R.; Chen, Z.; Scognamiglio, T.; et al. Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression. Elife 2017, 6, e20728. [Google Scholar] [CrossRef] [PubMed]
- Lister, J.A.; Capper, A.; Zeng, Z.; Mathers, M.E.; Richardson, J.; Paranthaman, K.; Jackson, I.J.; Patton, E.E. A conditional zebrafish MITF mutation reveals MITF levels are critical for melanoma promotion vs. regression in vivo. J. Investig. Dermatol. 2014, 134, 133–140. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Anelli, V.; Ordas, A.; Kneitz, S.; Sagredo, L.M.; Gourain, V.; Schartl, M.; Meijer, A.H.; Mione, M. Ras-Induced miR-146a and 193a Target Jmjd6 to Regulate Melanoma Progression. Front. Genet. 2018, 9, 675. [Google Scholar] [CrossRef] [Green Version]
- Park, S.W.; Davison, J.M.; Rhee, J.; Hruban, R.H.; Maitra, A.; Leach, S.D. Oncogenic KRAS Induces Progenitor Cell Expansion and Malignant Transformation in Zebrafish Exocrine Pancreas. Gastroenterology 2008, 134, 2080–2090. [Google Scholar] [CrossRef] [Green Version]
- Park, J.T.; Leach, S.D. Zebrafish model of KRAS-initiated pancreatic cancer. Anim. Cells Syst. 2018, 22, 353–359. [Google Scholar] [CrossRef] [Green Version]
- Chou, Y.T.; Chen, L.Y.; Tsai, S.L.; Tu, H.C.; Lu, J.W.; Ciou, S.C.; Wang, H.D.; Yuh, C.H. Ribose-5-Phosphate Isomerase a Overexpression Promotes Liver Cancer Development in Transgenic Zebrafish via Activation of ERK and beta-catenin Pathways. Carcinogenesis 2018, 40, 461–473. [Google Scholar] [CrossRef]
- Lu, J.W.; Raghuram, D.; Fong, P.A.; Gong, Z. Inducible Intestine-Specific Expression of kras(V12) Triggers Intestinal Tumorigenesis in Transgenic Zebrafish. Neoplasia 2018, 20, 1187–1197. [Google Scholar] [CrossRef]
- Yang, Q.; Yan, C.; Wang, X.; Gong, Z. Leptin induces muscle wasting in a zebrafish kras-driven hepatocellular carcinoma (HCC) model. Dis. Models Mech. 2019, 12, dmm038240. [Google Scholar] [CrossRef] [Green Version]
- Li, H.; Lu, J.W.; Huo, X.; Li, Y.; Li, Z.; Gong, Z. Effects of sex hormones on liver tumor progression and regression in Myc/xmrk double oncogene transgenic zebrafish. Gen. Comp. Endocrinol. 2019, 277, 112–121. [Google Scholar] [CrossRef] [PubMed]
- Enya, S.; Kawakami, K.; Suzuki, Y.; Kawaoka, S. A novel zebrafish intestinal tumor model reveals a role for cyp7a1-dependent tumor-liver crosstalk in causing adverse effects on the host. Dis. Models Mech. 2018, 11, dmm032383. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ceol, C.J.; Houvras, Y.; White, R.M.; Zon, L.I. Melanoma biology and the promise of zebrafish. Zebrafish 2008, 5, 247–255. [Google Scholar] [CrossRef] [PubMed]
- Davies, H.; Bignell, G.R.; Cox, C.; Stephens, P.; Edkins, S.; Clegg, S.; Teague, J.; Woffendin, H.; Garnett, M.J.; Bottomley, W.; et al. Mutations of the BRAF gene in human cancer. Nature 2002, 417, 949–954. [Google Scholar] [CrossRef]
- He, S.; Jing, C.B.; Look, A.T. Zebrafish models of leukemia. Methods Cell Biol. 2017, 138, 563–592. [Google Scholar]
- Langenau, D.M.; Feng, H.; Berghmans, S.; Kanki, J.P.; Kutok, J.L.; Look, A.T. Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 2005, 102, 6068–6073. [Google Scholar] [CrossRef] [Green Version]
- Potts, K.S.; Bowman, T.V. Modeling Myeloid Malignancies Using Zebrafish. Front. Oncol. 2017, 7, 297. [Google Scholar] [CrossRef]
- Yeh, J.R.; Munson, K.M.; Chao, Y.L.; Peterson, Q.P.; Macrae, C.A.; Peterson, R.T. AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression. Development 2008, 135, 401–410. [Google Scholar] [CrossRef] [Green Version]
- Dayyani, F.; Wang, J.; Yeh, J.R.; Ahn, E.Y.; Tobey, E.; Zhang, D.E.; Bernstein, I.D.; Peterson, R.T.; Sweetser, D.A. Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival. Blood 2008, 111, 4338–4347. [Google Scholar] [CrossRef] [Green Version]
- Zhuravleva, J.; Paggetti, J.; Martin, L.; Hammann, A.; Solary, E.; Bastie, J.N.; Delva, L. MOZ/TIF2-induced acute myeloid leukaemia in transgenic fish. Br. J. Haematol. 2008, 143, 378–382. [Google Scholar] [CrossRef]
- Onnebo, S.M.; Condron, M.M.; McPhee, D.O.; Lieschke, G.J.; Ward, A.C. Hematopoietic perturbation in zebrafish expressing a tel-jak2a fusion. Exp. Hematol. 2005, 33, 182–188. [Google Scholar] [CrossRef] [PubMed]
- Onnebo, S.M.; Rasighaemi, P.; Kumar, J.; Liongue, C.; Ward, A.C. Alternative TEL-JAK2 fusions associated with T-cell acute lymphoblastic leukemia and atypical chronic myelogenous leukemia dissected in zebrafish. Haematologica 2012, 97, 1895–1903. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chen, Y.; Pan, Y.; Guo, Y.; Zhao, W.; Ho, W.T.; Wang, J.; Xu, M.; Yang, F.C.; Zhao, Z.J. Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemia. Stem Cell Investig. 2017, 4, 48. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- He, B.L.; Shi, X.; Man, C.H.; Ma, A.C.; Ekker, S.C.; Chow, H.C.; So, C.W.; Choi, W.W.; Zhang, W.; Zhang, Y.; et al. Functions of flt3 in zebrafish hematopoiesis and its relevance to human acute myeloid leukemia. Blood 2014, 123, 2518–2529. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gjini, E.; Mansour, M.R.; Sander, J.D.; Moritz, N.; Nguyen, A.T.; Kesarsing, M.; Gans, E.; He, S.; Chen, S.; Ko, M.; et al. A zebrafish model of myelodysplastic syndrome produced through tet2 genomic editing. Mol. Cell. Biol. 2015, 35, 789–804. [Google Scholar] [CrossRef] [Green Version]
- Idilli, A.I.; Precazzini, F.; Mione, M.C.; Anelli, V. Zebrafish in Translational Cancer Research: Insight into Leukemia, Melanoma, Glioma and Endocrine Tumor Biology. Genes 2017, 8, 236. [Google Scholar] [CrossRef] [Green Version]
- Lu, J.W.; Hsieh, M.S.; Liao, H.A.; Yang, Y.J.; Ho, Y.J.; Lin, L.I. Zebrafish as a Model for the Study of Human Myeloid Malignancies. BioMed Res. Int. 2015, 2015, 641475. [Google Scholar] [CrossRef] [Green Version]
- Rasighaemi, P.; Basheer, F.; Liongue, C.; Ward, A.C. Zebrafish as a model for leukemia and other hematopoietic disorders. J. Hematol. Oncol. 2015, 8, 29. [Google Scholar] [CrossRef] [Green Version]
- Baeten, J.T.; de Jong, J.L.O. Genetic Models of Leukemia in Zebrafish. Front. Cell Dev. Biol. 2018, 6, 115. [Google Scholar] [CrossRef]
- Albacker, C.E.; Storer, N.Y.; Langdon, E.M.; Dibiase, A.; Zhou, Y.; Langenau, D.M.; Zon, L.I. The histone methyltransferase SUV39H1 suppresses embryonal rhabdomyosarcoma formation in zebrafish. PLoS ONE 2013, 8, e64969. [Google Scholar] [CrossRef]
- Ceol, C.J.; Houvras, Y.; Jane-Valbuena, J.; Bilodeau, S.; Orlando, D.A.; Battisti, V.; Fritsch, L.; Lin, W.M.; Hollmann, T.J.; Ferre, F.; et al. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature 2011, 471, 513–517. [Google Scholar] [CrossRef] [PubMed]
- Deveau, A.P.; Forrester, A.M.; Coombs, A.J.; Wagner, G.S.; Grabher, C.; Chute, I.C.; Leger, D.; Mingay, M.; Alexe, G.; Rajan, V.; et al. Epigenetic therapy restores normal hematopoiesis in a zebrafish model of NUP98-HOXA9-induced myeloid disease. Leukemia 2015, 29, 2086–2097. [Google Scholar] [CrossRef] [PubMed]
- Nasevicius, A.; Ekker, S.C. Effective targeted gene ’knockdown’ in zebrafish. Nat. Genet. 2000, 26, 216–220. [Google Scholar] [CrossRef] [PubMed]
- Doyon, Y.; McCammon, J.M.; Miller, J.C.; Faraji, F.; Ngo, C.; Katibah, G.E.; Amora, R.; Hocking, T.D.; Zhang, L.; Rebar, E.J.; et al. Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat. Biotechnol. 2008, 26, 702–708. [Google Scholar] [CrossRef] [Green Version]
- Huang, P.; Xiao, A.; Zhou, M.; Zhu, Z.; Lin, S.; Zhang, B. Heritable gene targeting in zebrafish using customized TALENs. Nat. Biotechnol. 2011, 29, 699–700. [Google Scholar] [CrossRef]
- Ablain, J.; Durand, E.M.; Yang, S.; Zhou, Y.; Zon, L.I. A CRISPR/Cas9 vector system for tissue-specific gene disruption in zebrafish. Dev. Cell 2015, 32, 756–764. [Google Scholar] [CrossRef] [Green Version]
- Amatruda, J.F.; Shepard, J.L.; Stern, H.M.; Zon, L.I. Zebrafish as a cancer model system. Cancer Cell 2002, 1, 229–231. [Google Scholar] [CrossRef] [Green Version]
- Kok, F.O.; Shin, M.; Ni, C.W.; Gupta, A.; Grosse, A.S.; van Impel, A.; Kirchmaier, B.C.; Peterson-Maduro, J.; Kourkoulis, G.; Male, I.; et al. Reverse Genetic Screening Reveals Poor Correlation between Morpholino-Induced and Mutant Phenotypes in Zebrafish. Dev. Cell 2015, 32, 97–108. [Google Scholar] [CrossRef] [Green Version]
- Stainier, D.Y.; Kontarakis, Z.; Rossi, A. Making sense of anti-sense data. Dev. Cell 2015, 32, 7–8. [Google Scholar] [CrossRef] [Green Version]
- Eve, A.M.; Place, E.S.; Smith, J.C. Comparison of Zebrafish tmem88a mutant and morpholino knockdown phenotypes. PLoS ONE 2017, 12, e0172227. [Google Scholar] [CrossRef]
- Rossi, A.; Kontarakis, Z.; Gerri, C.; Nolte, H.; Holper, S.; Kruger, M.; Stainier, D.Y. Genetic compensation induced by deleterious mutations but not gene knockdowns. Nature 2015, 524, 230–233. [Google Scholar] [CrossRef] [PubMed]
- Bolli, N.; Payne, E.M.; Grabher, C.; Lee, J.S.; Johnston, A.B.; Falini, B.; Kanki, J.P.; Look, A.T. Expression of the cytoplasmic NPM1 mutant (NPMc+) causes the expansion of hematopoietic cells in zebrafish. Blood 2010, 115, 3329–3340. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Auer, T.O.; Del Bene, F. CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish. Methods 2014, 69, 142–150. [Google Scholar] [CrossRef]
- Shin, J.; Padmanabhan, A.; de Groh, E.D.; Lee, J.S.; Haidar, S.; Dahlberg, S.; Guo, F.; He, S.; Wolman, M.A.; Granato, M.; et al. Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development. Dis. Models Mech. 2012, 5, 881–894. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bedell, V.M.; Wang, Y.; Campbell, J.M.; Poshusta, T.L.; Starker, C.G.; Krug, R.G., 2nd; Tan, W.; Penheiter, S.G.; Ma, A.C.; Leung, A.Y.; et al. In vivo genome editing using a high-efficiency TALEN system. Nature 2012, 491, 114–118. [Google Scholar] [CrossRef] [Green Version]
- Solin, S.L.; Shive, H.R.; Woolard, K.D.; Essner, J.J.; McGrail, M. Rapid tumor induction in zebrafish by TALEN-mediated somatic inactivation of the retinoblastoma1 tumor suppressor rb1. Sci. Rep. 2015, 5, 13745. [Google Scholar] [CrossRef] [Green Version]
- Shim, J.; Choi, J.H.; Park, M.H.; Kim, H.; Kim, J.H.; Kim, S.Y.; Hong, D.; Kim, S.; Lee, J.E.; Kim, C.H.; et al. Development of zebrafish medulloblastoma-like PNET model by TALEN-mediated somatic gene inactivation. Oncotarget 2017, 8, 55280–55297. [Google Scholar] [CrossRef] [Green Version]
- Yin, L.; Maddison, L.A.; Chen, W. Multiplex conditional mutagenesis in zebrafish using the CRISPR/Cas system. Methods Cell Biol. 2016, 135, 3–17. [Google Scholar]
- Moreno-Mateos, M.A.; Vejnar, C.E.; Beaudoin, J.D.; Fernandez, J.P.; Mis, E.K.; Khokha, M.K.; Giraldez, A.J. CRISPRscan: Designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo. Nat. Methods 2015, 12, 982–988. [Google Scholar] [CrossRef]
- Liu, K.; Petree, C.; Requena, T.; Varshney, P.; Varshney, G.K. Expanding the CRISPR Toolbox in Zebrafish for Studying Development and Disease. Front. Cell Dev. Biol. 2019, 7, 13. [Google Scholar] [CrossRef] [Green Version]
- Ablain, J.; Xu, M.; Rothschild, H.; Jordan, R.C.; Mito, J.K.; Daniels, B.H.; Bell, C.F.; Joseph, N.M.; Wu, H.; Bastian, B.C.; et al. Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma. Science 2018, 362, 1055–1060. [Google Scholar] [CrossRef] [Green Version]
- Burger, A.; Lindsay, H.; Felker, A.; Hess, C.; Anders, C.; Chiavacci, E.; Zaugg, J.; Weber, L.M.; Catena, R.; Jinek, M.; et al. Maximizing mutagenesis with solubilized CRISPR-Cas9 ribonucleoprotein complexes. Development 2016, 143, 2025–2037. [Google Scholar] [CrossRef] [Green Version]
- Wu, W.Y.; Lebbink, J.H.G.; Kanaar, R.; Geijsen, N.; van der Oost, J. Genome editing by natural and engineered CRISPR-associated nucleases. Nat. Chem. Biol. 2018, 14, 642–651. [Google Scholar] [CrossRef]
- Kleinstiver, B.P.; Sousa, A.A.; Walton, R.T.; Tak, Y.E.; Hsu, J.Y.; Clement, K.; Welch, M.M.; Horng, J.E.; Malagon-Lopez, J.; Scarfo, I.; et al. Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nat. Biotechnol. 2019, 37, 276–282. [Google Scholar] [CrossRef]
- Liu, P.; Luk, K.; Shin, M.; Idrizi, F.; Kwok, S.; Roscoe, B.; Mintzer, E.; Suresh, S.; Morrison, K.; Frazao, J.B.; et al. Enhanced Cas12a editing in mammalian cells and zebrafish. Nucleic Acids Res. 2019, 47, 4169–4180. [Google Scholar] [CrossRef] [Green Version]
- Fernandez, J.P.; Vejnar, C.E.; Giraldez, A.J.; Rouet, R.; Moreno-Mateos, M.A. Optimized CRISPR-Cpf1 system for genome editing in zebrafish. Methods 2018, 150, 11–18. [Google Scholar] [CrossRef]
- Liao, H.K.; Hatanaka, F.; Araoka, T.; Reddy, P.; Wu, M.Z.; Sui, Y.; Yamauchi, T.; Sakurai, M.; O’Keefe, D.D.; Nunez-Delicado, E.; et al. In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation. Cell 2017, 171, 1495–1507. [Google Scholar] [CrossRef] [Green Version]
- Plass, C.; Pfister, S.M.; Lindroth, A.M.; Bogatyrova, O.; Claus, R.; Lichter, P. Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nat. Rev. Genet. 2013, 14, 765–780. [Google Scholar] [CrossRef]
- Herceg, Z.; Ghantous, A.; Wild, C.P.; Sklias, A.; Casati, L.; Duthie, S.J.; Fry, R.; Issa, J.P.; Kellermayer, R.; Koturbash, I.; et al. Roadmap for investigating epigenome deregulation and environmental origins of cancer. Int. J. Cancer 2018, 142, 874–882. [Google Scholar] [CrossRef] [Green Version]
- Wee, S.; Dhanak, D.; Li, H.; Armstrong, S.A.; Copeland, R.A.; Sims, R.; Baylin, S.B.; Liu, X.S.; Schweizer, L. Targeting epigenetic regulators for cancer therapy. Ann. N. Y. Acad. Sci. 2014, 1309, 30–36. [Google Scholar] [CrossRef]
- Grimwade, D.; Ivey, A.; Huntly, B.J. Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance. Blood 2016, 127, 29–41. [Google Scholar] [CrossRef] [Green Version]
- Shih, A.H.; Meydan, C.; Shank, K.; Garrett-Bakelman, F.E.; Ward, P.S.; Intlekofer, A.; Nazir, A.; Stein, E.; Knapp, K.; Glass, J.; et al. Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia. Cancer Discov. 2017, 7, 494–505. [Google Scholar] [CrossRef] [Green Version]
- Kelly, A.D.; Issa, J.J. The promise of epigenetic therapy: Reprogramming the cancer epigenome. Curr. Opin. Genet. Dev. 2017, 42, 68–77. [Google Scholar] [CrossRef]
- Aspeslagh, S.; Morel, D.; Soria, J.C.; Postel-Vinay, S. Epigenetic modifiers as new immunomodulatory therapies in solid tumours. Ann. Oncol. 2018, 29, 812–824. [Google Scholar] [CrossRef]
- Wang, L.; Zhao, Z.; Ozark, P.A.; Fantini, D.; Marshall, S.A.; Rendleman, E.J.; Cozzolino, K.A.; Louis, N.; He, X.; Morgan, M.A.; et al. Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. Nat. Med. 2018, 24, 758–769. [Google Scholar] [CrossRef]
- Karanikolas, B.D.; Figueiredo, M.L.; Wu, L. Polycomb group protein enhancer of zeste 2 is an oncogene that promotes the neoplastic transformation of a benign prostatic epithelial cell line. Mol. Cancer Res. MCR 2009, 7, 1456–1465. [Google Scholar] [CrossRef] [Green Version]
- Ernst, T.; Chase, A.J.; Score, J.; Hidalgo-Curtis, C.E.; Bryant, C.; Jones, A.V.; Waghorn, K.; Zoi, K.; Ross, F.M.; Reiter, A.; et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat. Genet. 2010, 42, 722–726. [Google Scholar] [CrossRef]
- Zhu, J.; Sammons, M.A.; Donahue, G.; Dou, Z.; Vedadi, M.; Getlik, M.; Barsyte-Lovejoy, D.; Al-awar, R.; Katona, B.W.; Shilatifard, A.; et al. Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth. Nature 2015, 525, 206–211. [Google Scholar] [CrossRef] [Green Version]
- Shamma, A.; Takegami, Y.; Miki, T.; Kitajima, S.; Noda, M.; Obara, T.; Okamoto, T.; Takahashi, C. Rb Regulates DNA damage response and cellular senescence through E2F-dependent suppression of N-ras isoprenylation. Cancer Cell 2009, 15, 255–269. [Google Scholar] [CrossRef] [Green Version]
- Lam, S.H.; Chua, H.L.; Gong, Z.; Lam, T.J.; Sin, Y.M. Development and maturation of the immune system in zebrafish, Danio rerio: A gene expression profiling, in situ hybridization and immunological study. Dev. Comp. Immunol. 2004, 28, 9–28. [Google Scholar] [CrossRef]
- Traver, D.; Winzeler, A.; Stern, H.M.; Mayhall, E.A.; Langenau, D.M.; Kutok, J.L.; Look, A.T.; Zon, L.I. Effects of lethal irradiation in zebrafish and rescue by hematopoietic cell transplantation. Blood 2004, 104, 1298–1305. [Google Scholar] [CrossRef] [Green Version]
- Langenau, D.M.; Ferrando, A.A.; Traver, D.; Kutok, J.L.; Hezel, J.P.; Kanki, J.P.; Zon, L.I.; Look, A.T.; Trede, N.S. In vivo tracking of T cell development, ablation, and engraftment in transgenic zebrafish. Proc. Natl. Acad. Sci. USA 2004, 101, 7369–7374. [Google Scholar] [CrossRef] [Green Version]
- King, M.A.; Covassin, L.; Brehm, M.A.; Racki, W.; Pearson, T.; Leif, J.; Laning, J.; Fodor, W.; Foreman, O.; Burzenski, L.; et al. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin. Exp. Immunol. 2009, 157, 104–118. [Google Scholar] [CrossRef]
- Tang, Q.; Abdelfattah, N.S.; Blackburn, J.S.; Moore, J.C.; Martinez, S.A.; Moore, F.E.; Lobbardi, R.; Tenente, I.M.; Ignatius, M.S.; Berman, J.N.; et al. Optimized cell transplantation using adult rag2 mutant zebrafish. Nat. Meth. 2014, 11, 821–824. [Google Scholar] [CrossRef] [Green Version]
- Stoletov, K.; Montel, V.; Lester, R.D.; Gonias, S.L.; Klemke, R. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc. Natl. Acad. Sci. USA 2007, 104, 17406–17411. [Google Scholar] [CrossRef] [Green Version]
- Mizgireuv, I.V.; Revskoy, S.Y. Transplantable tumor lines generated in clonal zebrafish. Cancer Res. 2006, 66, 3120–3125. [Google Scholar] [CrossRef] [Green Version]
- Smith, A.C.; Raimondi, A.R.; Salthouse, C.D.; Ignatius, M.S.; Blackburn, J.S.; Mizgirev, I.V.; Storer, N.Y.; de Jong, J.L.; Chen, A.T.; Zhou, Y.; et al. High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia. Blood 2010, 115, 3296–3303. [Google Scholar] [CrossRef] [Green Version]
- De La Rochere, P.; Guil-Luna, S.; Decaudin, D.; Azar, G.; Sidhu, S.S.; Piaggio, E. Humanized Mice for the Study of Immuno-Oncology. Trends Immunol. 2018, 39, 748–763. [Google Scholar] [CrossRef]
- Tang, Q.; Moore, J.C.; Ignatius, M.S.; Tenente, I.M.; Hayes, M.N.; Garcia, E.G.; Torres Yordan, N.; Bourque, C.; He, S.; Blackburn, J.S.; et al. Imaging tumour cell heterogeneity following cell transplantation into optically clear immune-deficient zebrafish. Nat. Commun. 2016, 7, 10358. [Google Scholar] [CrossRef]
- Moore, J.C.; Tang, Q.; Yordan, N.T.; Moore, F.E.; Garcia, E.G.; Lobbardi, R.; Ramakrishnan, A.; Marvin, D.L.; Anselmo, A.; Sadreyev, R.I.; et al. Single-cell imaging of normal and malignant cell engraftment into optically clear prkdc-null SCID zebrafish. J. Exp. Med. 2016, 213, 2575–2589. [Google Scholar] [CrossRef]
- Heilmann, S.; Ratnakumar, K.; Langdon, E.M.; Kansler, E.R.; Kim, I.S.; Campbell, N.R.; Perry, E.B.; McMahon, A.J.; Kaufman, C.K.; van Rooijen, E.; et al. A Quantitative System for Studying Metastasis Using Transparent Zebrafish. Cancer Res. 2015, 75, 4272–4282. [Google Scholar] [CrossRef] [Green Version]
- Benjamin, D.C.; Hynes, R.O. Intravital imaging of metastasis in adult Zebrafish. BMC Cancer 2017, 17, 660. [Google Scholar] [CrossRef] [Green Version]
- Hyenne, V.; Ghoroghi, S.; Collot, M.; Bons, J.; Follain, G.; Harlepp, S.; Mary, B.; Bauer, J.; Mercier, L.; Busnelli, I.; et al. Studying the Fate of Tumor Extracellular Vesicles at High Spatiotemporal Resolution Using the Zebrafish Embryo. Dev. Cell 2019, 48, 554–572. [Google Scholar] [CrossRef] [Green Version]
- Lee, L.M.; Seftor, E.A.; Bonde, G.; Cornell, R.A.; Hendrix, M.J. The fate of human malignant melanoma cells transplanted into zebrafish embryos: Assessment of migration and cell division in the absence of tumor formation. Dev. Dyn. 2005, 233, 1560–1570. [Google Scholar] [CrossRef]
- Topczewska, J.M.; Postovit, L.M.; Margaryan, N.V.; Sam, A.; Hess, A.R.; Wheaton, W.W.; Nickoloff, B.J.; Topczewski, J.; Hendrix, M.J. Embryonic and tumorigenic pathways converge via Nodal signaling: Role in melanoma aggressiveness. Nat. Med. 2006, 12, 925–932. [Google Scholar] [CrossRef]
- Haldi, M.; Ton, C.; Seng, W.L.; McGrath, P. Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis 2006, 9, 139–151. [Google Scholar] [CrossRef]
- Olszewski, M.B.; Pruszko, M.; Snaar-Jagalska, E.; Zylicz, A.; Zylicz, M. Diverse and cancer typespecific roles of the p53 R248Q gainoffunction mutation in cancer migration and invasiveness. Int. J. Oncol. 2019, 54, 1168–1182. [Google Scholar]
- Zhang, B.; Xuan, C.; Ji, Y.; Zhang, W.; Wang, D. Zebrafish xenotransplantation as a tool for in vivo cancer study. Fam. Cancer 2015, 14, 487–493. [Google Scholar] [CrossRef]
- Cabezas-Sainz, P.; Guerra-Varela, J.; Carreira, M.J.; Mariscal, J.; Roel, M.; Rubiolo, J.A.; Sciara, A.A.; Abal, M.; Botana, L.M.; Lopez, R.; et al. Improving zebrafish embryo xenotransplantation conditions by increasing incubation temperature and establishing a proliferation index with ZFtool. BMC Cancer 2018, 18, 3. [Google Scholar] [CrossRef]
- Marques, I.J.; Weiss, F.U.; Vlecken, D.H.; Nitsche, C.; Bakkers, J.; Lagendijk, A.K.; Partecke, L.I.; Heidecke, C.D.; Lerch, M.M.; Bagowski, C.P. Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer 2009, 9, 14. [Google Scholar] [CrossRef] [Green Version]
- Nicoli, S.; Presta, M. The zebrafish/tumor xenograft angiogenesis assay. Nat. Protoc. 2007, 2, 2918–2923. [Google Scholar] [CrossRef]
- Nicoli, S.; Ribatti, D.; Cotelli, F.; Presta, M. Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res. 2007, 67, 2927–2931. [Google Scholar]
- Zhao, C.; Wang, X.; Zhao, Y.; Li, Z.; Lin, S.; Wei, Y.; Yang, H. A novel xenograft model in zebrafish for high-resolution investigating dynamics of neovascularization in tumors. PLoS ONE 2011, 6, e21768. [Google Scholar] [CrossRef] [Green Version]
- Chiavacci, E.; Rizzo, M.; Pitto, L.; Patella, F.; Evangelista, M.; Mariani, L.; Rainaldi, G. The zebrafish/tumor xenograft angiogenesis assay as a tool for screening anti-angiogenic miRNAs. Cytotechnology 2015, 67, 969–975. [Google Scholar] [CrossRef] [Green Version]
- Cheng, S.Y.; Chen, N.F.; Lin, P.Y.; Su, J.H.; Chen, B.H.; Kuo, H.M.; Sung, C.S.; Sung, P.J.; Wen, Z.H.; Chen, W.F. Anti-Invasion and Antiangiogenic Effects of Stellettin B through Inhibition of the Akt/Girdin Signaling Pathway and VEGF in Glioblastoma Cells. Cancers 2019, 11, 220. [Google Scholar] [CrossRef] [Green Version]
- Gabellini, C.; Gomez-Abenza, E.; Ibanez-Molero, S.; Tupone, M.G.; Perez-Oliva, A.B.; de Oliveira, S.; Del Bufalo, D.; Mulero, V. Interleukin 8 mediates bcl-xL-induced enhancement of human melanoma cell dissemination and angiogenesis in a zebrafish xenograft model. Int. J. Cancer 2018, 142, 584–596. [Google Scholar] [CrossRef]
- Corkery, D.P.; Dellaire, G.; Berman, J.N. Leukaemia xenotransplantation in zebrafish--chemotherapy response assay in vivo. Br. J. Haematol. 2011, 153, 786–789. [Google Scholar] [CrossRef]
- Pruvot, B.; Jacquel, A.; Droin, N.; Auberger, P.; Bouscary, D.; Tamburini, J.; Muller, M.; Fontenay, M.; Chluba, J.; Solary, E. Leukemic cell xenograft in zebrafish embryo for investigating drug efficacy. Haematologica 2011, 96, 612–616. [Google Scholar] [CrossRef] [Green Version]
- Bentley, V.L.; Veinotte, C.J.; Corkery, D.P.; Pinder, J.B.; LeBlanc, M.A.; Bedard, K.; Weng, A.P.; Berman, J.N.; Dellaire, G. Focused chemical genomics using zebrafish xenotransplantation as a preclinical therapeutic platform for T-cell acute lymphoblastic leukemia. Haematologica 2015, 100, 70–76. [Google Scholar] [CrossRef]
- Lin, J.; Zhang, W.; Zhao, J.J.; Kwart, A.H.; Yang, C.; Ma, D.; Ren, X.; Tai, Y.T.; Anderson, K.C.; Handin, R.I.; et al. A clinically relevant in vivo zebrafish model of human multiple myeloma to study preclinical therapeutic efficacy. Blood 2016, 128, 249–252. [Google Scholar] [CrossRef]
- Sacco, A.; Roccaro, A.M.; Ma, D.; Shi, J.; Mishima, Y.; Moschetta, M.; Chiarini, M.; Munshi, N.; Handin, R.I.; Ghobrial, I.M. Cancer Cell Dissemination and Homing to the Bone Marrow in a Zebrafish Model. Cancer Res. 2016, 76, 463–471. [Google Scholar] [CrossRef] [Green Version]
- van der Ent, W.; Burrello, C.; Teunisse, A.F.; Ksander, B.R.; van der Velden, P.A.; Jager, M.J.; Jochemsen, A.G.; Snaar-Jagalska, B.E. Modeling of human uveal melanoma in zebrafish xenograft embryos. Investig. Ophthalmol. Vis. Sci. 2014, 55, 6612–6622. [Google Scholar] [CrossRef]
- Teng, Y.; Xie, X.; Walker, S.; White, D.T.; Mumm, J.S.; Cowell, J.K. Evaluating human cancer cell metastasis in zebrafish. BMC Cancer 2013, 13, 453. [Google Scholar] [CrossRef] [Green Version]
- Vittori, M.; Breznik, B.; Hrovat, K.; Kenig, S.; Lah, T.T. RECQ1 Helicase Silencing Decreases the Tumour Growth Rate of U87 Glioblastoma Cell Xenografts in Zebrafish Embryos. Genes 2017, 8, 222. [Google Scholar] [CrossRef] [Green Version]
- Lam, S.H.; Lee, S.G.; Lin, C.Y.; Thomsen, J.S.; Fu, P.Y.; Murthy, K.R.; Li, H.; Govindarajan, K.R.; Nick, L.C.; Bourque, G.; et al. Molecular conservation of estrogen-response associated with cell cycle regulation, hormonal carcinogenesis and cancer in zebrafish and human cancer cell lines. BMC Med. Genom. 2011, 4, 41. [Google Scholar] [CrossRef] [Green Version]
- Ghotra, V.P.; He, S.; de Bont, H.; van der Ent, W.; Spaink, H.P.; van de Water, B.; Snaar-Jagalska, B.E.; Danen, E.H. Automated whole animal bio-imaging assay for human cancer dissemination. PLoS ONE 2012, 7, e31281. [Google Scholar] [CrossRef]
- Drabsch, Y.; He, S.; Zhang, L.; Snaar-Jagalska, B.E.; ten Dijke, P. Transforming growth factor-beta signalling controls human breast cancer metastasis in a zebrafish xenograft model. Breast Cancer Res. BCR 2013, 15, R106. [Google Scholar] [CrossRef]
- Naber, H.P.; Drabsch, Y.; Snaar-Jagalska, B.E.; ten Dijke, P.; van Laar, T. Snail and Slug, key regulators of TGF-beta-induced EMT, are sufficient for the induction of single-cell invasion. Biochem. Biophys. Res. Commun. 2013, 435, 58–63. [Google Scholar] [CrossRef]
- Truong, H.H.; Xiong, J.; Ghotra, V.P.; Nirmala, E.; Haazen, L.; Le Devedec, S.E.; Balcioglu, H.E.; He, S.; Snaar-Jagalska, B.E.; Vreugdenhil, E.; et al. beta1 integrin inhibition elicits a prometastatic switch through the TGFbeta-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancer. Sci. Signal. 2014, 7, ra15. [Google Scholar] [CrossRef]
- de Boeck, M.; Cui, C.; Mulder, A.A.; Jost, C.R.; Ikeno, S.; Ten Dijke, P. Smad6 determines BMP-regulated invasive behaviour of breast cancer cells in a zebrafish xenograft model. Sci. Rep. 2016, 6, 24968. [Google Scholar] [CrossRef] [Green Version]
- Tulotta, C.; Stefanescu, C.; Beletkaia, E.; Bussmann, J.; Tarbashevich, K.; Schmidt, T.; Snaar-Jagalska, B.E. Inhibition of signaling between human CXCR4 and zebrafish ligands by the small molecule IT1t impairs the formation of triple-negative breast cancer early metastases in a zebrafish xenograft model. Dis. Models Mech. 2016, 9, 141–153. [Google Scholar] [CrossRef] [Green Version]
- Tulotta, C.; Stefanescu, C.; Chen, Q.; Torraca, V.; Meijer, A.H.; Snaar-Jagalska, B.E. CXCR4 signaling regulates metastatic onset by controlling neutrophil motility and response to malignant cells. Sci. Rep. 2019, 9, 2399. [Google Scholar] [CrossRef] [Green Version]
- Ben-Porath, I.; Thomson, M.W.; Carey, V.J.; Ge, R.; Bell, G.W.; Regev, A.; Weinberg, R.A. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 2008, 40, 499–507. [Google Scholar] [CrossRef]
- Finicelli, M.; Benedetti, G.; Squillaro, T.; Pistilli, B.; Marcellusi, A.; Mariani, P.; Santinelli, A.; Latini, L.; Galderisi, U.; Giordano, A. Expression of stemness genes in primary breast cancer tissues: The role of SOX2 as a prognostic marker for detection of early recurrence. Oncotarget 2014, 5, 9678–9688. [Google Scholar] [CrossRef] [Green Version]
- Schaefer, T.; Wang, H.; Mir, P.; Konantz, M.; Pereboom, T.C.; Paczulla, A.M.; Merz, B.; Fehm, T.; Perner, S.; Rothfuss, O.C.; et al. Molecular and functional interactions between AKT and SOX2 in breast carcinoma. Oncotarget 2015, 6, 43540–43556. [Google Scholar] [CrossRef]
- Mercatali, L.; La Manna, F.; Groenewoud, A.; Casadei, R.; Recine, F.; Miserocchi, G.; Pieri, F.; Liverani, C.; Bongiovanni, A.; Spadazzi, C.; et al. Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model. Int. J. Mol. Sci. 2016, 17, 1375. [Google Scholar] [CrossRef]
- Ghotra, V.P.; He, S.; van der Horst, G.; Nijhoff, S.; de Bont, H.; Lekkerkerker, A.; Janssen, R.; Jenster, G.; van Leenders, G.J.; Hoogland, A.M.; et al. SYK Is a Candidate Kinase Target for the Treatment of Advanced Prostate Cancer. Cancer Res. 2015, 75, 230–240. [Google Scholar] [CrossRef] [Green Version]
- Melong, N.; Steele, S.; MacDonald, M.; Holly, A.; Collins, C.C.; Zoubeidi, A.; Berman, J.N.; Dellaire, G. Enzalutamide inhibits testosterone-induced growth of human prostate cancer xenografts in zebrafish and can induce bradycardia. Sci. Rep. 2017, 7, 14698. [Google Scholar] [CrossRef] [Green Version]
- Xu, W.; Foster, B.A.; Richards, M.; Bondioli, K.R.; Shah, G.; Green, C.C. Characterization of prostate cancer cell progression in zebrafish xenograft model. Int. J. Oncol. 2018, 52, 252–260. [Google Scholar] [CrossRef] [Green Version]
- Chen, X.; Wang, J.; Cao, Z.; Hosaka, K.; Jensen, L.; Yang, H.; Sun, Y.; Zhuang, R.; Liu, Y.; Cao, Y. Invasiveness and metastasis of retinoblastoma in an orthotopic zebrafish tumor model. Sci. Rep. 2015, 5, 10351. [Google Scholar] [CrossRef] [Green Version]
- Welker, A.M.; Jaros, B.D.; An, M.; Beattie, C.E. Changes in tumor cell heterogeneity after chemotherapy treatment in a xenograft model of glioblastoma. Neuroscience 2017, 356, 35–43. [Google Scholar] [CrossRef]
- Zeng, A.; Ye, T.; Cao, D.; Huang, X.; Yang, Y.; Chen, X.; Xie, Y.; Yao, S.; Zhao, C. Identify a Blood-Brain Barrier Penetrating Drug-TNB using Zebrafish Orthotopic Glioblastoma Xenograft Model. Sci. Rep. 2017, 7, 14372. [Google Scholar] [CrossRef] [Green Version]
- Banasavadi-Siddegowda, Y.K.; Welker, A.M.; An, M.; Yang, X.; Zhou, W.; Shi, G.; Imitola, J.; Li, C.; Hsu, S.; Wang, J.; et al. PRMT5 as a druggable target for glioblastoma therapy. Neuro Oncol. 2018, 20, 753–763. [Google Scholar] [CrossRef]
- Pudelko, L.; Edwards, S.; Balan, M.; Nyqvist, D.; Al-Saadi, J.; Dittmer, J.; Almlof, I.; Helleday, T.; Brautigam, L. An orthotopic glioblastoma animal model suitable for high-throughput screenings. Neuro Oncol. 2018, 20, 1475–1484. [Google Scholar] [CrossRef]
- Ellis, H.P.; Greenslade, M.; Powell, B.; Spiteri, I.; Sottoriva, A.; Kurian, K.M. Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence. Front. Oncol. 2015, 5, 251. [Google Scholar] [CrossRef] [Green Version]
- Roel, M.; Rubiolo, J.A.; Guerra-Varela, J.; Silva, S.B.; Thomas, O.P.; Cabezas-Sainz, P.; Sanchez, L.; Lopez, R.; Botana, L.M. Marine guanidine alkaloids crambescidins inhibit tumor growth and activate intrinsic apoptotic signaling inducing tumor regression in a colorectal carcinoma zebrafish xenograft model. Oncotarget 2016, 7, 83071–83087. [Google Scholar] [CrossRef] [Green Version]
- Chang, T.C.; Wei, P.L.; Makondi, P.T.; Chen, W.T.; Huang, C.Y.; Chang, Y.J. Bromelain inhibits the ability of colorectal cancer cells to proliferate via activation of ROS production and autophagy. PLoS ONE 2019, 14, e0210274. [Google Scholar] [CrossRef]
- Wu, J.Q.; Zhai, J.; Li, C.Y.; Tan, A.M.; Wei, P.; Shen, L.Z.; He, M.F. Patient-derived xenograft in zebrafish embryos: A new platform for translational research in gastric cancer. J. Exp. Clin. Cancer Res. CR 2017, 36, 160. [Google Scholar] [CrossRef] [Green Version]
- Tsering, J.; Hu, X. Triphala Suppresses Growth and Migration of Human Gastric Carcinoma Cells In Vitro and in a Zebrafish Xenograft Model. BioMed Res. Int. 2018, 2018, 7046927. [Google Scholar] [CrossRef] [Green Version]
- Yu, C.I.; Chen, C.Y.; Liu, W.; Chang, P.C.; Huang, C.W.; Han, K.F.; Lin, I.P.; Lin, M.Y.; Lee, C.H. Sandensolide Induces Oxidative Stress-Mediated Apoptosis in Oral Cancer Cells and in Zebrafish Xenograft Model. Mar. Drugs 2018, 16, 387. [Google Scholar] [CrossRef] [Green Version]
- Jin, Y.; Wei, L.; Jiang, Q.; Song, X.; Teng, C.; Fan, C.; Lv, Y.; Liu, Y.; Shen, W.; Li, L.; et al. Comparison of efficacy and toxicity of bevacizumab, endostar and apatinib in transgenic and human lung cancer xenograftzebrafish model. Sci. Rep. 2018, 8, 15837. [Google Scholar] [CrossRef]
- Chou, H.L.; Lin, Y.H.; Liu, W.; Wu, C.Y.; Li, R.N.; Huang, H.W.; Chou, C.H.; Chiou, S.J.; Chiu, C.C. Combination Therapy of Chloroquine and C(2)-Ceramide Enhances Cytotoxicity in Lung Cancer H460 and H1299 Cells. Cancers 2019, 11, 370. [Google Scholar] [CrossRef] [Green Version]
- van der Ent, W.; Jochemsen, A.G.; Teunisse, A.F.; Krens, S.F.; Szuhai, K.; Spaink, H.P.; Hogendoorn, P.C.; Snaar-Jagalska, B.E. Ewing sarcoma inhibition by disruption of EWSR1-FLI1 transcriptional activity and reactivation of p53. J. Pathol. 2014, 233, 415–424. [Google Scholar] [CrossRef]
- Zhang, B.; Shimada, Y.; Kuroyanagi, J.; Nishimura, Y.; Umemoto, N.; Nomoto, T.; Shintou, T.; Miyazaki, T.; Tanaka, T. Zebrafish xenotransplantation model for cancer stem-like cell study and high-throughput screening of inhibitors. Tumor Biol. 2014, 35, 11861–11869. [Google Scholar] [CrossRef]
- Khan, N.; Mahajan, N.K.; Sinha, P.; Jayandharan, G.R. An efficient method to generate xenograft tumor models of acute myeloid leukemia and hepatocellular carcinoma in adult zebrafish. Blood Cells Mol. Dis. 2019, 75, 48–55. [Google Scholar] [CrossRef]
- Yan, C.; Brunson, D.C.; Tang, Q.; Do, D.; Iftimia, N.A.; Moore, J.C.; Hayes, M.N.; Welker, A.M.; Garcia, E.G.; Dubash, T.D.; et al. Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish. Cell 2019, 177, 1903–1914. [Google Scholar] [CrossRef]
- Zhao, S.; Huang, J.; Ye, J. A fresh look at zebrafish from the perspective of cancer research. J. Exp. Clin. Cancer Res. CR 2015, 34, 80. [Google Scholar] [CrossRef] [Green Version]
- Wang, C.; Tao, W.; Wang, Y.; Bikow, J.; Lu, B.; Keating, A.; Verma, S.; Parker, T.G.; Han, R.; Wen, X.Y. Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer. Eur. Urol. 2010, 58, 418–426. [Google Scholar] [CrossRef]
- White, R.M.; Cech, J.; Ratanasirintrawoot, S.; Lin, C.Y.; Rahl, P.B.; Burke, C.J.; Langdon, E.; Tomlinson, M.L.; Mosher, J.; Kaufman, C.; et al. DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature 2011, 471, 518–522. [Google Scholar] [CrossRef] [Green Version]
- Ridges, S.; Heaton, W.L.; Joshi, D.; Choi, H.; Eiring, A.; Batchelor, L.; Choudhry, P.; Manos, E.J.; Sofla, H.; Sanati, A.; et al. Zebrafish screen identifies novel compound with selective toxicity against leukemia. Blood 2012, 119, 5621–5631. [Google Scholar] [CrossRef] [Green Version]
- Gutierrez, A.; Pan, L.; Groen, R.W.; Baleydier, F.; Kentsis, A.; Marineau, J.; Grebliunaite, R.; Kozakewich, E.; Reed, C.; Pflumio, F.; et al. Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia. J. Clin. Investig. 2014, 124, 644–655. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Precazzini, F.; Pancher, M.; Gatto, P.; Tushe, A.; Adami, V.; Anelli, V.; Mione, M.C. Automated in vivo screen in zebrafish identifies Clotrimazole as targeting a metabolic vulnerability in a melanoma model. Dev. Biol. 2019, in press. [Google Scholar] [CrossRef] [PubMed]
- Stern, H.M.; Murphey, R.D.; Shepard, J.L.; Amatruda, J.F.; Straub, C.T.; Pfaff, K.L.; Weber, G.; Tallarico, J.A.; King, R.W.; Zon, L.I. Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat. Chem. Biol. 2005, 1, 366–370. [Google Scholar] [CrossRef] [PubMed]
- Camus, S.; Quevedo, C.; Menendez, S.; Paramonov, I.; Stouten, P.F.; Janssen, R.A.; Rueb, S.; He, S.; Snaar-Jagalska, B.E.; Laricchia-Robbio, L.; et al. Identification of phosphorylase kinase as a novel therapeutic target through high-throughput screening for anti-angiogenesis compounds in zebrafish. Oncogene 2012, 31, 4333–4342. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Murphy, A.G.; Casey, R.; Maguire, A.; Tosetto, M.; Butler, C.T.; Conroy, E.; Reynolds, A.L.; Sheahan, K.; O’Donoghue, D.; Gallagher, W.M.; et al. Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer. Sci. Rep. 2016, 6, 34523. [Google Scholar] [CrossRef] [Green Version]
- Astin, J.W.; Jamieson, S.M.; Eng, T.C.; Flores, M.V.; Misa, J.P.; Chien, A.; Crosier, K.E.; Crosier, P.S. An in vivo antilymphatic screen in zebrafish identifies novel inhibitors of mammalian lymphangiogenesis and lymphatic-mediated metastasis. Mol. Cancer 2014, 13, 2450–2462. [Google Scholar] [CrossRef] [Green Version]
- Dang, M.; Henderson, R.E.; Garraway, L.A.; Zon, L.I. Long-term drug administration in the adult zebrafish using oral gavage for cancer preclinical studies. Dis. Models Mech. 2016, 9, 811–820. [Google Scholar] [CrossRef] [Green Version]
- Tamplin, O.J.; White, R.M.; Jing, L.; Kaufman, C.K.; Lacadie, S.A.; Li, P.; Taylor, A.M.; Zon, L.I. Small molecule screening in zebrafish: Swimming in potential drug therapies. Wiley Interdiscip. Rev. Dev. Biol. 2012, 1, 459–468. [Google Scholar] [CrossRef]
- Gutierrez-Lovera, C.; Vazquez-Rios, A.J.; Guerra-Varela, J.; Sanchez, L.; de la Fuente, M. The Potential of Zebrafish as a Model Organism for Improving the Translation of Genetic Anticancer Nanomedicines. Genes 2017, 8, 349. [Google Scholar] [CrossRef] [Green Version]
- Ito, M.; Hiramatsu, H.; Kobayashi, K.; Suzue, K.; Kawahata, M.; Hioki, K.; Ueyama, Y.; Koyanagi, Y.; Sugamura, K.; Tsuji, K.; et al. NOD/SCID/gamma(c)(null) mouse: An excellent recipient mouse model for engraftment of human cells. Blood 2002, 100, 3175–3182. [Google Scholar] [CrossRef]
- Murphey, R.D.; Zon, L.I. Small molecule screening in the zebrafish. Methods 2006, 39, 255–261. [Google Scholar] [CrossRef] [PubMed]
Cancer | Genotype | Zebrafish Background | Reference |
---|---|---|---|
Peripheral nerve sheath tumor (PNST) | tp53M214K | WT | [39] |
brca2Q658X tp53M214K | WT or tp53M214K | [47] | |
PNST, angiosarcoma, leukemia, germ cell tumor | tp53del/del | CG1 syngeneic zebrafish strain | [40] |
Rhabdomyosarcoma (RMS) | rag2:KRASG12D rag2:dsRed2 | WT; α-actin:GFP; tp53M214K | [43,44] |
Melanoma | BRAFV600E tp53M214K | tp53M214K | [45] |
BRAFV600E tp53M214K | crestin:EGFP; tp53M214K | [50] | |
BRAFV600Emitfavc7 | mitfavc7 | [54] | |
hsp70I:GFP-HRASG12V | N.A. | [51,55] | |
kita:GalTA4,UAS:mCherry UAS:eGFP-HRASGV12 | N.A. | [52,55] | |
kita:Gal4TA, UAS:mCherry UAS:eGFP-HRASGV12 UAS:eGFP-jmjd6 | WT or tp53M214K | [55] | |
Thyroid cancer | tg:BRAFV600E-pA;tg:TdTomato-pA | WT | [53] |
Pancreatic cancer | ptf1a:eGFP-KRASG12V | WT | [56] |
ptf1a:CREERT2 ubb:lox-Nuc-eCFP-stop-lox-GAL4-VP16 UAS:eGFP-KRASG12V | N.A. | [57] | |
Hepatocellular cancer (HCC) | fabp10a: RPIA; myl7:GFP | N.A. | [58] |
fabp10:rtTA2s-M2;TRE2:eGFP-krasG12V | WT or lepr+/- | [60] | |
fabp10:TA; TRE:Myc; krt4:GFP fabp10:TA; TRE:xmrk; krt4:GFP | WT | [61] | |
Intestinal tumors | pDs-ifabp:LexPR-Lexop:eGFP-krasV12 | N.A. | [59] |
5×UAS:EGFP-P2A-krasG12D fabp10a:mCherry fabp10a:mCherry-P2A-cyp7a1 + various Gal4 lines | WT or cyp7a1−5 | [62] | |
Testicular tumor | brca2Q658X | WT | [48] |
T-cell acute lymphoid leukemia (T-ALL) | rag2:mMyc rag2:GFP rag2:dsRed2 | WT | [42,43] |
rag2:loxP-dsRED2-loxP-eGFP-mMyc | WT | [66] | |
spi1:tel-jak2a | WT | [72] | |
Acute lymphoid leukemia (AML) | hsp70:AML1-ETO | WT | [68,69] |
spi1:MYST3/NCOA2-eGFP | N.A. | [70] | |
pHsFLT3-WT-T2a-eGFP pHsFLT3-ITD-T2a-eGFP FLT3-ITD-T2a-mRFP | WT | [74] | |
Chronic myeloid leukemia (CML) | spi1:tel-jak2a | WT | [71,72] |
Myelodysplastic syndrome (MDS) | tet2-/- | cmyb:eGFP; cd41:eGFP | [75] |
Cancer | Zebrafish Genotype | Epigenetic Regulator | Function | Reference |
---|---|---|---|---|
RMS | rag2-hKRASG12D | SUV39H1 | Tumor suppressor | [80] |
Melanoma | BRAFV600E tp53M214K | SETDB1 | Oncogene | [81] |
AML | NUP98-HOXA9 | dnmt1 | Oncogene | [82] |
Retinoblastoma | rb1/rb1 | more than 170 tested e.g., hdac1, rbbp4 | Oncogenes | [36] |
Transplanted Cancer Type | Developmental Stage | Injection Site | Reference | |
---|---|---|---|---|
Primary cells | T-ALL | Adult | Intraperitoneal cavity | [42,66,124,127] |
RMS | Adult | Intraperitoneal cavity | [124,127] | |
Melanoma | Adult | Intraperitoneal cavity | [124] | |
T-ALL, RMS, melanoma, neuroblastoma | Adult | Intraperitoneal cavity, retro-orbital, intramuscular | [129,130] | |
Melanoma | Adult | N.A. | [131] | |
ZMELs | Melanoma | Adult 48 h post-fertilization (hpf) | Subcutaneous Circulation (duct of Cuvier) | [131] |
Adult | Retro-orbital Intravenous (cardinal vein) | [132] | ||
48 hpf | Circulation | [133] |
Transplanted Cancer Type | Developmental Stage | Injection Site | Reference | |
---|---|---|---|---|
Cell lines | Melanoma | Blastula | Blastodisc | [134] |
Melanoma (uveal and cutaneous) | Blastula | N.A. | [135] | |
Melanoma and colorectal cancer | 48 h post-fertilization (hpf) | Yolk sac; hindbrain ventricle; circulation | [136] | |
Uveal melanoma | 48 hpf | Yolk sac | [152] | |
Melanoma | 48 hpf | Yolk sac | [146] | |
Colorectal cancer | 48 hpf | Yolk sac | [139] | |
Colorectal cancer | 48 hpf | Yolk sac | [27,176,177] | |
Pancreatic cancer | 48 hpf | Yolk sac | [140] | |
Melanoma, adenocarcinoma, triple negative breast cancer (TNBC) and ovarian cancer | 48 hpf | Yolk sac, proximity of subintestinal veins (SIV) | [141,142] | |
Colorectal cancer, melanoma (both murine) | 48 hpf | Yolk sac | [143] | |
Prostate cancer | 48 hpf | Yolk sac | [144,167] | |
Prostate cancer, androgen dependent and independent | 48 hpf | Yolk sac | [168] | |
Prostate cancer | 48 hpf | Subcutaneous, above yol sack | [169] | |
Breast, prostate, colon, pancreatic cancer, fibrosarcoma | 48 hpf | Yolk sac | [153] | |
Breast cancer | 48 hpf | Yolk sac | [25] | |
Breast, prostate, colorectal cancer | 48 hpf | Yolk sac | [156] | |
Breast cancer, non-invasive and metastatic | 48 hpf | Duct of Cuvier | [157] | |
Breast cancer | 48 hpf | Duct of Cuvier | [158] | |
Breast cancer | 48 hpf | Yolk sac | [159] | |
Breast adenocarcinoma and TNBC | 48 hpf | Duct of Cuvier | [161] | |
TNBC and prostate cancer | 48 hpf | Duct of Cuvier | [162] | |
Breast cancer | 48 hpf | Yolk sac | [165] | |
Breast cancer and TNBC | 48 hpf | Duct of Cuvier | [166] | |
TNBC | 48 hpf | Duct of Cuvier | [165] | |
AML, CML | 48 hpf | Yolk sac | [147] | |
Cell lines | AML, T-ALL | 48 hpf | Posterior cardinal vein (PCV) | [148] |
T-ALL | 48 hpf | Yolk sac | [149] | |
Multiple myeloma (MM) | 48 hpf | Yolk sac | [150] | |
MM, Waldenstrom’s macroglobulinemia, TNBC | 48 hpf | Pericardium | [151] | |
CML, HCC, prostate cancer (sorted for cancer stem cells) | 48 hpf Adult | Yolk sac Trunk near dorsal aorta | [184] | |
AML, HCC | 48 hpf Adult | Yolk sac Trunk near dorsal aorta; heart | [185] | |
Retinoblastoma | 48 hpf | Vitreous cavity | [170] | |
Glioblastoma | 52 hpf | Yolk sack; brain | [154] | |
Glioblastoma | 36 hpf | Hindbrain | [171] | |
Glioblastoma | 72 hpf | Brain | [172] | |
Glioblastoma and colon cancer | Blastula | Blastoderm | [174] | |
Gastrointestinal tumors – pancreas, stomach, colon | 48 hpf | Yolk sac; liver | [140] | |
Gastric cancer | 48 hpf | Yolk sac | [178,179] | |
Oral squamous cell carcinoma | 48 hpf | Yolk sac | [180] | |
Non-small-cell lung cancer (NSCLC) | 48 hpf | Yolk sac | [181] | |
NCSLC | 48 hpf | N.A. | [182] | |
Ewing sarcoma (EWS) | 48 hpf Juvenile (35 dpf) | Yolk sac Eye vessels | [183] | |
Various types of human cancer | Adult | Intraperitoneal cavity Peri-ocular muscle | [186] | |
PDX | AML blast cells | 48 hpf | PCV | [148] |
T-ALL from bone marrow | 48 hpf | Yolk sac | [149] | |
MM cells from plasma | 48 hpf | Yolk sac | [150] | |
MM cells from bone marrow | 48 hpf | Pericardium | [151] | |
Glioblastoma | 36 hpf | Brain | [173] | |
Glioblastoma | blastula | Blastoderm | [174] | |
Gastric cancer | 48 hpf | Yolk sac | [178] | |
Glioblastoma, melanoma, breast cancer, RMS | Adult | Peri-ocular muscle | [186] |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Hason, M.; Bartůněk, P. Zebrafish Models of Cancer—New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate. Genes 2019, 10, 935. https://doi.org/10.3390/genes10110935
Hason M, Bartůněk P. Zebrafish Models of Cancer—New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate. Genes. 2019; 10(11):935. https://doi.org/10.3390/genes10110935
Chicago/Turabian StyleHason, Martina, and Petr Bartůněk. 2019. "Zebrafish Models of Cancer—New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate" Genes 10, no. 11: 935. https://doi.org/10.3390/genes10110935
APA StyleHason, M., & Bartůněk, P. (2019). Zebrafish Models of Cancer—New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate. Genes, 10(11), 935. https://doi.org/10.3390/genes10110935